Behavioral measures and self-report of impulsivity in bipolar disorder: no association between Stroop test and Barratt Impulsiveness Scale by Elisa Sophie Strasser et al.
Strasser et al. Int J Bipolar Disord  (2016) 4:16 
DOI 10.1186/s40345-016-0057-1
RESEARCH
Behavioral measures and self-report 
of impulsivity in bipolar disorder: no association 
between Stroop test and Barratt Impulsiveness 
Scale
Elisa Sophie Strasser1*, Paula Haffner1, Jana Fiebig1, Esther Quinlivan1, Mazda Adli1,2 and Thomas Josef Stamm1
Abstract 
Background: Impulsivity as a tendency to act quickly without considering future consequences has been proposed 
as a dimensional factor in bipolar disorder. It can be measured using behavioral tasks and self-report questionnaires. 
Previous findings revealed patients to show worse performance on at least one behavioral measure of impulsivity. 
Additionally, self-reported impulsivity seems to be higher among bipolar patients, both parameters being possibly 
associated with a more severe course of illness. In this study, our primary aim was to investigate the relationship 
between these two constructs of impulsivity among bipolar patients.
Methods: A total of 40 euthymic patients with bipolar disorder (21 female, 22 Bipolar I) and 30 healthy controls were 
recruited for comprehensive neuropsychological assessment. To assess inhibition control as a behavioral measure of 
impulsivity, the Stroop Color and Word Test (Stroop) was used. Additionally, both groups completed the Barratt Impul-
siveness Scale (BIS) as a self-report of impulsivity. To compare the groups’ performance on the Stroop and ratings on 
the BIS, the non-parametric Mann–Whitney U test was used. Within the bipolar group, we additionally examined the 
possibility of an association between Stroop performance and BIS total scores using Pearson’s Correlation r.
Results: Patients and controls differed significantly on the Stroop and BIS, with patients performing worse on the 
Stroop and scoring higher on the BIS. However, there was no association between the Stroop and BIS within the bipo-
lar group. As an exploratory analysis, a positive correlation between Stroop performance and number of episodes was 
found. Further, we detected a statistical trend in the direction of poorer Stroop performance among patients treated 
with polypharmacy.
Conclusions: Both difficulties with behavioral inhibition and self-reported impulsivity were observed to be higher in 
bipolar patients than controls in the current study. However, within the patient group we did not observe an associa-
tion between patients’ behavioral performance and self-report. This indicates that the parameters likely constitute 
distinct, dimensional factors of bipolar disorder. In future research, studies with larger samples should investigate 
which of the two markers constitutes the better marker for the illness and is more suitable to differentiate the most 
severe patients.
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Background
The term “bipolar disorder” implicates a disorder with 
both manic/hypomanic and depressive episodes (APA 
1994). Thus, patients seem to experience either one 
extreme or the other. However, this definition disre-
gards a number of factors that are present throughout all 
phases of the illness, including euthymia (Levy and Man-
ove 2012). For this reason, establishing a better under-
standing of such particular dimensional factors present 
in bipolar disorders is warranted (Henry and Etain 2010). 
This may be an interesting area of inquiry, as dimen-
sional factors may represent indicators for specific treat-
ment response and thus guide treatment. If subgroups of 
patients with specific dimensional characteristics were 
to be identified, it could help investigate possible patho-
physiological mechanisms (Henry and Etain 2010).
For instance, impulsivity as one possible dimensional 
factor in bipolar disorder (Henry and Etain 2010) impli-
cates the tendency to act quickly without considering 
future consequences (Hamilton et  al. 2015). Impulsiv-
ity can be measured using behavioral tasks and by self-
report questionnaires (Hamilton et al. 2015).
Inhibition control reflects a behavioral manifestation of 
impulsivity (Newman and Meyer 2014), and constitutes 
one of the core domains of executive function, which can 
be divided into response inhibition and interference con-
trol (Diamond 2013). Interference control can be meas-
ured using the Stroop Color and Word Test (Stroop) 
(Stroop 1992). Interference control constitutes a gating 
mechanism, which helps to ignore irrelevant information 
(Wilson and Kipp 1998) and enhances the ability to sup-
press stimuli that would ordinarily trigger a competing 
reaction. Additionally, it activates the ability to suppress 
distractors which would ordinarily delay the response 
(Nigg 2000). Dempster (1992, p. 47) emphasized the 
importance of “the ability to inhibit or deactivate stored 
information” as being “just as decisive as the quantity and 
quality of stored information and the availability of acti-
vation resources”.
Another aspect of inhibition involves the ability to con-
trol attention, behavior, thoughts, and emotions, as well 
as the ability to resist internal or external urges or temp-
tations (Diamond 2013). This definition of inhibition is 
similar to the construct of self-reported impulsiveness 
applied by Patton et al. (1995) who developed the Barratt 
impulsivity scale (BIS). The BIS is a 30-item rating scale, 
where each item is related to one of three second-order 
facets of impulsivity: These include attentional impul-
siveness referring to quick cognitive decision-making, 
motor impulsiveness which refers to acting without think-
ing, and non-planning impulsiveness which refers to a 
lack of future planning (Patton et al. 1995).
Both behavioral and self-reported impulsivity impli-
cate important clinical consequences. Inhibition con-
trol—or more precisely, interference control, measured 
by Stroop—may represent a possible endophenotype 
of bipolar disorders, given that even non-afflicted first-
degree relatives of individuals with bipolar disorder seem 
to show poorer Stroop performance (Arts et  al. 2008). 
Furthermore, an association has been found between 
decreased interference control and period of time to 
recovery among first-episode patients (Gruber et  al. 
2008) as well as between decreased interference control 
and unemployment among bipolar patients (Ryan et  al. 
2013). High impulsivity scores measured by the BIS are 
associated with increases in overall functional impair-
ment (Jimenez et  al. 2012), a higher number of epi-
sodes at early onset and a higher number of past suicide 
attempts (Swann et al. 2009), as well as with increases in 
substance consumption, including alcohol (Nery et  al. 
2013) and nicotine (Heffner et al. 2012).
Previous findings revealed significant differences 
between bipolar patients and healthy controls in terms 
of both the BIS as self-reported impulsivity (Swann 
et al. 2001, 2003, 2004; Peluso et al. 2007; Kathleen Hol-
mes et al. 2009; Strakowski et al. 2010; Ekinci et al. 2011; 
Lombardo et  al. 2012; Henna et  al. 2013; Etain et  al. 
2013) and the Stroop as behavioral impulsivity (Rob-
inson et  al. 2006; Torres et  al. 2007; Arts et  al. 2008; 
Kurtz and Gerraty 2009; Bora et al. 2009; Mann-Wrobel 
et  al. 2011). Furthermore, what has been perplexing to 
date has been the huge variance in performance on the 
Stroop in a number of meta-analyses, with little explana-
tion of why this may be the case (Robinson et  al. 2006; 
Torres et  al. 2007; Arts et  al. 2008; Kurtz and Gerraty 
2009; Bora et  al. 2009; Mann-Wrobel et  al. 2011; Hajek 
et al. 2013). A recent review summarized several studies 
investigating either behavioral or self-reported impulsiv-
ity, which revealed predominantly significant differences 
in self-reported, but not behavioral tests of impulsivity 
(Newman and Meyer 2014). However, few studies have 
examined the link between these two constructs, and it 
is notable that to date no study has investigated the rela-
tionship between the Stroop and the BIS among bipolar 
patients as its primary research question. If observed, a 
positive relationship could further support the clinical 
utility of the BIS as an easily administrated, economical 
screening tool when assessing bipolar patients. In addi-
tion to existing knowledge about the BIS and course of 
illness, suicidality and substance misuse, it may be pos-
sible to gain a more nuanced understanding of behavioral 
impulsivity’s relationship with these phenomenon. This 
would have positive implications for clinical practice, 
insofar as it would aid clinicians in making a brief yet 
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detailed assessment of a patient’s presentation and clini-
cal needs.
The current research aimed to investigate the relation-
ship of self-reported impulsivity (measured by the BIS) 
and a behavioral measure of inhibition control (Stroop 
test) in bipolar patients. Initially, we sought to confirm 
previous findings that bipolar patients show a poorer 
performance on the Stroop and a higher BIS score com-
pared to healthy controls. Then, as main research ques-
tion, we sought to examine whether poorer performance 
on a behavioral test of impulsivity was related to higher 
self-reported impulsivity in a group of bipolar patients.
Additionally, we wanted to investigate a possible asso-
ciation between impulsivity measures and possible con-
founders, such as number of episodes, subthreshold 
depressive symptoms, medical treatment, and years of 
education in an exploratory analysis.
Methods
Participants
A total of 50 bipolar patients (29 female, 27 Bipolar I) and 
43 healthy controls were seen for a comprehensive neu-
ropsychological assessment. All patients were recruited 
from the psychiatric outpatient clinic at the Charité Mitte 
Campus University Hospital in Berlin based on the fol-
lowing inclusion criteria: diagnosis of bipolar disorder 
according to the DSM-IV; clinical remission meeting the 
criteria of euthymia [Hamilton Depression Rating Scale 
version 21 (HAMD-21) (Hamilton 1960) ≤9 and Young 
Mania Rating Scale (YMRS) (Young et al. 1978) ≤12] for 
at least 6  weeks; absence of affective symptoms; medi-
cation with a mood stabilizer for at least three months; 
minimum age of 18 years. A number of strictly euthymic 
patients were systematically looked for, to achieve a broad 
range of patients’ composition (i.e., those with a HAMD-
21 ≤ 3, based on practice in a recent study regarding sub-
threshold symptoms in bipolar disorder) (Bonnin et  al. 
2012). Patients were excluded if they met the criteria of 
current psychotic symptoms, substance abuse during the 
last three months, dementia or mild cognitive impair-
ment, or other predominant Axis I disorder within the 
past six months. Diagnoses using DSM-IV were under-
taken by experienced and trained assessors with more 
than five years of experience with clinical diagnostics. 
YMRS and HAMD-21 were administered by well-trained 
assessors.
Healthy controls were recruited by web advertisement 
and word of mouth and were at least 18  years old. Cri-
teria for exclusion were diagnosis of any current or past 
Axis1 disorder, assessed by the Mini-International Neu-
ropsychiatric Interview (M.I.N.I.) (Sheehan et  al. 1998), 
and first-degree relatives with an affective disorder or 
schizophrenia.
From the 50 patients originally recruited, ten were 
excluded for the following reasons: five emerged to be 
in a depressive mood state during testing, one emerged 
to have a mild cognitive impairment, three were not 
medicated with a mood stabilizer and one was not in a 
euthymic state for the required minimum six weeks. Of 
the 43 healthy controls, nine were excluded on the basis 
of a depressive episode (current or lifetime) or current 
substance abuse. To avoid the emergence of an age effect 
on the Stroop task (Comalli et al. 1962), we ensured that 
participants in both groups were of similar age by sys-
tematically removing the four youngest of the 34 healthy 
controls fulfilling the inclusion criteria.
Patients and controls within this study concurrently 
participated in two different studies using the same neu-
ropsychological assessment: 34 patients participated in 
a pilot study investigating the feasibility of metacogni-
tive training for low-functioning bipolar patients (Haf-
fner et al. 2016), and 16 patients participated in a study 
on cognitive vulnerability in bipolar patients (Quinlivan 
et al. 2016).
Assessment
A number of previous studies have used the Stroop as a 
measure of inhibitory control (Enticott et al. 2006; Kemps 
and Wilsdon 2010). In the current study, to measure a 
lack of inhibitory control as a behavioral manifestation 
of impulsivity [as has been previously indicated (New-
man and Meyer 2014)] a German version of the Stroop 
interference (Bäumler and Stroop 1985) was applied. The 
outcome variable used was the time needed to complete 
the test. In the absence of a discrete measure of behavio-
ral impulsivity, the use of a measure of inhibitory control 
was considered an appropriate alternative. The German 
version of the Stroop test shows an internal consistency 
of 0.97 and a retest reliability of 0.93. The facture struc-
ture as well as convergent and divergent validity have 
been confirmed (Bäumler and Stroop 1985). To assess 
self-reported impulsivity, the BIS-11 questionnaire was 
used. Regarding validity and reliability of the German 
version of the BIS-11 scale, the BIS total score showed 
adequate internal consistencies (Preuss et  al. 2008) and 
findings of a study investigating adolescents ascertained 
convergent validity and suggested appropriate reliability 
(Hartmann et al. 2011).
As an interviewer-administered rating scale for the 
impairment of psychosocial functioning in bipolar disor-
der, the Functional Assessment Short Test (FAST) (Rosa 
et  al. 2007) was administered with both patients and 
controls.
To assess general neurocognitive functioning, 
including executive functions, verbal memory, intel-
ligence and attention, all participants completed a 
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neuropsychological test battery. Executive functions were 
assessed by a German word fluency task (Regensburger 
Wortflüssigkeitstest) (Aschenbrenner et  al. 2000) and 
digit span backwards subtest of the German version of 
the Wechsler memory scale (WMS) (Härting et al. 2000). 
Verbal memory was measured by the German verbal 
learning and memory test (Verbaler Lern- und Merk-
fähigkeitstest, VLMT) (Helmstaedter et al. 2001) and the 
digit span forward as a subtest of the WMS. The subtest 
LPS3 of a German intelligence test battery (Leistung-
sprüfsystem, LPS) (Horn 1983) was used to assess logical 
thinking as fluid intelligence whereas a multiple choice 
vocabulary test (Mehrfach Wortschatz Test, MWT-B) 
(Lehrl 2005) measured crystallized intelligence. Further-
more different aspects of attention and executive func-
tion were examined using subtests (alertness and divided 
attention) of a German computerized test battery (Test-
batterie zur Aufmerksamkeitsprüfung, TAP) (Zimmer-
man and Fimm 2006). A well-trained assessor delivered 
the comprehensive neuropsychological battery and all 
participants were tested in similar circumstances con-
cerning place, time, person and instructions.
Data analysis
As a number of our variables were not normally dis-
tributed, use of the non-parametric Mann–Whitney U 
test was indicated. The test was completed to compare 
patients and healthy controls on a range of variables, 
including demographics, clinical features and facets of 
the neuropsychological assessments. Fisher’s exact test 
was applied on normative variables (e.g., gender). For 
our confirmatory analyses, the Mann–Whitney U test 
was used to compare patients and healthy controls con-
cerning time needed in the Stroop and scoring in the 
BIS (both in terms of total and subscale scores). Because 
of patients and controls differing on the BDI, a regres-
sion analysis was conducted to explore, whether the 
BDI predicts Stroop and, respectively, BIS. A second 
Mann–Whitney U test was then applied to compare the 
15 strictly euthymic patients’ (with HAMD-21 ≤ 3) and 
controls’ Stroop performance and BIS scores. In terms of 
our primary question, time needed in the Stroop inter-
ference and BIS total scores was correlated according 
to Pearson within the patient group. To investigate pos-
sible confounders of the Stroop test probably being the 
more robust measure, exploratory analyses were con-
ducted. This was completed by correlating time needed 
in the Stroop interference with six possible confounders 
available in our dataset, such as subthreshold depressive 
symptoms (as measured by the HAMD-21), subthreshold 
manic symptoms (as measured by the YMRS), years of 
education, duration of illness, number of hospitalizations 
and the FAST cognitive score. Because of the explorative 
character of these correlations, we did not perform a type 
II error correction. Data analyses were conducted using 
IBM SPSS Statistics Version 22.0.
Results
Of the 40 patients fulfilling the inclusion criteria, 15 
had a HAMD-21  ≤  3 which indicated that they were 
strictly euthymic at the time of testing. An overview of 
the demographics and clinical characteristics is shown in 
Table 1.
First, we observed that patients needed significantly 
more time to complete the Stroop interference task than 
healthy controls (z = −2.49, p =  .01, r =  .30, for all BIS 
and Stroop scores see Table 2). Patients also scored signif-
icantly higher on self-reported impulsivity, as measured 
by the BIS total score (z = −2.08, p = .04, r = .25). With 
regard to the three subscales on the BIS, patients scored 
significantly higher than controls in terms of attentional 
impulsiveness (z = −3.67, p ≤ .001, r = .44) and non-plan-
ning impulsiveness (z = −1.98, p < .05, r = .24). However, 
for the motor impulsiveness subscale no significant differ-
ences were observed, see Fig. 1 and Table 2.
Because of the above-analyzed groups differing on the 
BDI (a self-rating scale for depressive symptoms, see 
Table 1), additional analyses were run: A regression anal-
yses showed that concerning the whole sample of patients 
and controls, the BDI could not significantly explain any 
variance of the Stroop (R2 = .00, p = .88) whereas it could 
explain 20.3 % of variance of the BIS (R2 = .20, p < .001). 
Thus, respecting the BDI as a possible confounder in the 
comparison between patients and controls, in a second 
step an additional comparison between the 15 strictly 
euthymic patients (HAMD-21  ≤  3) and the 30 healthy 
controls was conducted. Groups did not differ on the 
BDI, nor concerning age or, respectively, gender (all p 
values >.05). Now, patients and controls significantly dif-
fered only on the Stroop (z = −2.25, p = .02, r = .34), but 
not on the BIS total score (z = −1.68, p =  .09). Regard-
ing the BIS sub-scores, only the BIS attentional remained 
significantly different between patients and controls 
(z = −2.26, p = .02, r = .34), whereas there was no statis-
tical difference concerning the sub-scores non-planning 
and motor (all p values >.05).
In regard to our primary research question, data showed 
no significant positive correlation between patients’ test 
performance on the Stroop and total BIS scores (n =  39 
due to the exclusion of one outlier on the Stroop, r = −.09, 
p = .60). Similarly, we did not observe any significant cor-
relations when we examined time needed on the Stroop 
with the respective BIS subscales (attentional, motor and 
non-planning impulsiveness). Therefore, in the current 
study’s sample of bipolar patients, self-reported impulsiv-
ity was not related to behavioral inhibition performance 
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on the Stroop. The two constructs were positively corre-
lated neither regarding healthy controls (n = 29 due to the 
exclusion of one outlier on the Stroop, r = .13, p = .49) nor 
in the whole sample (n = 69, due to the exclusion of one 
outlier on the Stroop, r = .06, p = .61).
The Stroop showed to possibly constitute a more exact 
measure which seems more independent of current 
symptoms than the BIS. Therefore, possible associations 
between the Stroop and six possible confounders were 
further explored. We observed a significant correlation 
between time needed on the Stroop and number of mood 
episodes (n = 39 due to one outlier; r = .34; p = .03). We 
also observed a trend in the direction of significance for 
time needed on the Stroop and number of different psy-
chotropic medication groups (n = 39, r =  .31; p =  .06). 
However, there was no association between Stroop per-
formance and subthreshold depression (as measured by 
the HAMD-21), subthreshold manic symptoms (as meas-
ured by the YMRS), years of education, duration of illness 
and number of hospitalizations (all p’s >  .05). Regarding 
the FAST Cognitive score, there was a positive correla-
tion with Stroop performance (r = .339; p = .04).
Table 1 Demographic and clinical characteristics of bipolar patients (BD) and healthy controls (HC)
M mean, Mdn median, SD standard deviation, IQR interquartile range, ◊ Mann–Whitney U test, × Fisher’s exact test, n.s. ≥ .05
Variable BD HC Statistics
n M/Mdn/n Range n M/Mdn/n Range
Gender female 40 21 (52.50 %) 30 18 (60.00 %) × n.s.
Age (years) Mdn (IQR) 40 48.00 (21.00) 23–77 30 38.50 (21.00) 26–63 ◊ n.s.
Years of education Mdn (IQR) 40 18.00 (5.00) 11–18 30 15.50 (6.00) 11–18 ◊ n.s.
Number of episodes M (SD) 40 21.78 (15.04) 3–72 – –
Age at onset M (SD) 40 29.10 (11.59) 13–58 – –
Duration of illness in years M (SD) 40 18.00 (10.87) 1–48
Number of hospitalizations M (SD) 40 2.93 (2.94) 0–12
Prior suicide attempts M (SD) 40 0.45 (1.06) 0–5 – –
Bipolar 1 40 22 (55.00 %) – –
Rapid cycling lifetime 40 7 (17.50 %) – –
Past psychotic symptoms 39 11 (28 %)
Number of different psychotropic 
treatment groups M (SD)
40 1.88 (0.79) – –
Treatment with lithium 40 19 (47.50 %) – –
Treatment with antipsychotics 40 16 (40.00 %) – –
Treatment with antiepileptics 40 26 (65.00 %) – –
Treatment with antidepressants 40 15 (37.50 %) – –
BDI Mdn (IQR) (Beck et al. 1961) 39 5.00 (15.00) 0–26 30 2.00 (6.00) 0–10 ◊ z = −3.08 p ≤ .01 r = .37
HAMD M (SD) 40 5.05 (2, 90) 0–9 – –
YMRS-D M (SD) 40 1.50 (2, 08) 0–9 – –
FAST general score Mdn (IQR) 40 23.00 (16.75) 0–45 30 2.00 (5.00) 0–8 ◊ z = −6.53 p ≤ .001 r = .78
FAST cognitive score Mdn (IQR) 40 5.00 (5.75) 0–11 30 1.00 (2.00) 0–4 ◊ z = −5.82 p ≤ .001 r = .70
Table 2 Scores of  Stroop and  BIS of  all euthymic patients (HAMD-21 ≤  9), the strictly euthymic subgroup of  patients 
(HAMD-21 ≤ 3) and healthy controls
M mean, Mdn median, SD standard deviation, IQR interquartile range
Variable Euthymic patients n = 40 Strictly euthymic patients n = 15 Healthy controls n = 30
Mdn (IQR) M (SD) Mdn (IQR) M (SD) Mdn (IQR) M (SD)
Stroop 81.00 (27.50) 82.65 (18.16) 88.00 (31.00) 85.27 (17.38) 71.50 (17.5) 73.53 (16.56)
BIS total 63.00 (16.00) 63.20 (9.71) 63.00 (18.00) 63.33 (9.91) 58.00 (7.75) 58.23 (7.67)
BIS attention 15.00 (5.00) 16.10 (3.54) 15.00 (5.00) 15.07 (2.76) 13.00 (3.00) 13.17 (2.51)
BIS motor 21.50 (4.75) 21.88 (3.71) 22.00 (5.00) 22.80 (3.78) 22.50 (4.25) 22.03 (3.09)
BIS non-planning 26.00 (6.75) 25.23 (4.64) 26.00 (8.00) 25.47 (5.22) 23.50 (5.00) 23.03 (4.55)
Page 6 of 10Strasser et al. Int J Bipolar Disord  (2016) 4:16 
With respect to our descriptive analysis of neurocog-
nitive function, patients performed similar to healthy 
controls across nearly all domains of the neuropsycho-
logical test battery. Thus, there were no significant dif-
ferences in tests of memory, attention and intelligence. 
Regarding executive functions, patients showed signif-
icantly worse results in the two word fluency tests (i.e., 
word fluency naming animals: Mdn patients =  24.00, 
Mdn controls  =  26.50, z  =  −2.21, p  =  .03, r  =  .26; 
and word fluency S-words: Mdn patients  =  14.00, 
Mdn controls = 16.50, z = −2.36, p = .02, r = .28). As 
regards to number of errors in the Stroop interference 
task, no significant difference was observed between 
the groups; however, there was a trend in this direc-
tion (M patients  =  .97 Mdn patients  =  .00, M con-
trols  =  .27 Mdn controls  =  .00, z  =  −1.91, p  =  .06, 
r = .23).
Discussion
Aside from exploratory research, this study is the first 
to comprehensively investigate the relationship between 
behavioral and self-reported impulsivity, using the 
Stroop Test and the BIS in a sample of bipolar patients. 
Patients showed poorer Stroop performance and higher 
BIS scores than controls, yet our most striking finding 
was the absence of a positive correlation between Stroop 
performance and BIS reports within the bipolar group. 
Moreover, our study revealed promising exploratory 
findings regarding the relationship of inhibition control 
and number of episodes and medication.
A notable strength of the current study lies in the 
range of patients sampled, including a number of 
strictly euthymic patients and a subgroup of particularly 
low-functioning patients (see Table  1). Thus, we have 
accounted for and considered the diversity of bipolar 
patients and minimized possible important biases when 
comparing patients and controls on their test perfor-
mance. For the healthy controls for instance, we ensured 
an absence of any first-degree relatives with an affec-
tive disorder or schizophrenia, given the potential for 
inhibition and impulsivity as possible endophenotypes. 
The detailed neurocognitive test battery facilitated us 
to achieve a broad profile of the sample, supporting the 
study’s strength.
Comparing Stroop performance of patients and healthy 
controls
We found a significant difference between patients’ and 
controls’ Stroop test performance with a medium effect 
size. This is in accordance with previous meta-analytical 
findings (Robinson et  al. 2006; Torres et  al. 2007; Arts 
et  al. 2008; Kurtz and Gerraty 2009; Bora et  al. 2009; 
Mann-Wrobel et  al. 2011), with the exception of one 
(Hajek et al. 2013). It is notable that even when compar-
ing the group of strictly euthymic patients to healthy con-









































Stroop = Stroop Color and Word interference BIS = Barratt Impulsiveness Scale
p-values for the Mann-Whitney U test * p <.05 (2-tailed) ** p <.001 (2-tailed) 
BD HC
Fig. 1 Behavioral and self-reported impulsivity of euthymic patients (n = 40) and healthy controls (n = 30). On the Stroop test, poorer performance 
is indicated by higher scores (i.e., longer response duration). On the BIS, higher scores also indicated a greater affliction (i.e., more impulsive self-
reports). Note: when comparing the subgroup of strictly euthymic patients to healthy controls, only the Stroop and the BIS sub-score attentional 
stay significantly different
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Comparing BIS scores of patients and healthy controls
Equally, in terms of self-reported impulsivity, we were 
able to confirm previous studies in which bipolar patients 
showed a higher BIS total score than healthy controls 
(Swann et al. 2001, 2003, 2004; Peluso et al. 2007; Kath-
leen Holmes et  al. 2009; Strakowski et  al. 2010; Ekinci 
et al. 2011; Lombardo et al. 2012; Henna et al. 2013). A 
study, investigating a total of 504 healthy controls, meas-
ured a BIS total score of M = 59.25 (SD = 9.31) (Aichert 
et al. 2012); a finding similar to that of our healthy con-
trols. Thus, patients in our sample are more impulsive 
than population norms, pointing towards the considera-
tion of impulsivity as a trait characteristic of bipolar dis-
order, independent of current illness phase.
It should be noted, however, that there is an associa-
tion between the BIS and self-report of depressive symp-
toms, suggesting that the BIS as a self-report might not 
be suitable as a trait marker. When comparing the group 
of strictly euthymic patients to the healthy controls, the 
difference concerning the BIS total score was no more 
significant (although the strictly euthymic subgroup 
showing the same BIS total score as the whole bipolar 
sample). Only the BIS sub-score attentional stayed signif-
icantly different between patients and healthy controls. 
This might imply that the BIS attentional could be the 
more exact measure. This would be in accordance with 
a previous study on the early diagnosis of bipolar disor-
der, where the BIS sub-score attentional, but not the total 
score, showed to be a good marker predicting onset of 
(hypo)mania in subjects at risk (Ng et al. 2016).
Two studies reported an absence of differences (Chris-
todoulou et al. 2006; Lewis et al. 2009) between patients 
and healthy controls, indicating that this research ques-
tion warrants thorough inquiry.
The relationship between behavioral and self‑reported 
impulsivity in bipolar disorder
In our findings, there was no relationship between Stroop 
interference and the BIS; neither in terms of the total 
or subscale scores. Based on how items are constructed 
in relation to concentration and distraction on the BIS 
attention subscale, it would in fact have been expected 
that this subscale would be the most likely to correlate 
with Stroop performance. Our findings are in accord-
ance with exploratory results of one study (Powers et al. 
2013), which similar to us observed a lack of correla-
tion between Stroop performance (amongst seven other 
neurocognitive test parameters) and the BIS. Thus, the 
present study can confidently confirm this exploratory 
finding and support a recent review which proposed that 
self-report and behavioral measures of impulsivity might 
indeed reflect distinct theoretical constructs (Newman 
and Meyer 2014).
In terms of other populations—both general and clini-
cal—poorer performance in the Stroop interference has 
been found to be associated with higher impulsivity. 
Correlations with the Stroop have been observed within 
a group of healthy subjects when tested using the BIS 
(Enticott et al. 2006), as well as with other clinical groups 
where problems with impulsivity are noteworthy; for 
example, for patients with borderline personality disor-
der (Bader and 2010) and bulimia nervosa (Kemps and 
Wilsdon 2010). On closer examination, however, in the 
borderline subgroup (Bader and 2010) there were multi-
ple inventories of impulsivity correlated with several tests 
of impulsivity, and no Type II error correction for mul-
tiple tests was applied. Further, in the small study which 
sampled patients with bulimia (n  =  13), after BIS was 
entered as a covariate, a significant difference between 
patients and controls on Stroop performance was no 
longer observed (Kemps and Wilsdon 2010). Due to the 
lack of robustness of these findings, it is only possible 
to conclude that a relationship between BIS and Stroop 
performance is feasible. In the study with healthy sub-
jects (Enticott et  al. 2006), a spatial Stroop was imple-
mented as a reading-independent test, and participants 
were not older than 51 (unlike in our study, where par-
ticipants ranged from 23 to 77 years of age). This study 
correlated four different behavioral paradigms of impul-
sivity with the BIS and its subscales, revealing that only 
the Stroop task correlated significantly. It is possible that 
a relationship between the Stroop and BIS may have been 
more easily detected in a younger sample, given that age 
may influence Stroop performance (Comalli et al. 1962). 
Other studies using a range of different populations did 
not observe a relationship between the Stroop task and 
BIS at all (Enticott et al. 2008; Aichert et al. 2012). Inter-
estingly, one study investigated four measures of pre-
potent response inhibition, including the Stroop, and 
the BIS in a sample of 504 healthy individuals. While 
Stroop did not correlate with BIS, a latent variable anal-
ysis revealed all four measures of response inhibition to 
be underpinned by the same construct, where the BIS 
explained 12  % of the variance (Aichert et  al. 2012). In 
light of these mostly exploratory findings, the current 
results seem to contribute to a controversial database, 
where overall there has been, at best, a small relationship 
between behavioral and self-reported impulsivity when 
using these particular measures.
Studies using tests other than the Stroop to investigate 
the relationship between self-reported impulsivity and 
inhibitory control as a measure of behavioral impulsiv-
ity within bipolar patients have partially found evidence 
for a positive correlation. However, these studies were 
mostly exploratory. For example, Cheema et  al. (2015) 
found higher BIS scores to be associated with slower 
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reaction times in an emotional Go/No-go test, inter-
preted by the authors as a possible compensatory cogni-
tive strategy to manage increased impulsivity. However, 
this correlation was one of many tests run without the 
use of an error correction, again indicating the possibility 
for Type II error. Beyond that, the consideration of multi-
ple other test findings are warranted. For instance, higher 
attentional BIS scores have been associated with a lower 
response inhibition in the Hayling Sentence Completion 
test (Christodoulou et al. 2006). BIS motor score has been 
correlated with more impulsive behavior in the Balloon 
Analogue Risk Task (Kathleen Holmes et al. 2009). How-
ever, BIS impulsivity has not been found to be related 
to decreased inhibition in the Stop Signal Task (Heffner 
et al. 2012). The discrepancies in findings of theoretically 
similar constructs render it difficult to make meaning-
ful conclusions regarding the nature of impulsivity. It is 
notable, however, that these differences may be attribut-
able to a lack of consistency in the methods and measures 
used; for example, the various procedures of the behav-
ioral tests of impulsivity which were not always shown to 
inter-correlate (Enticott et al. 2006).
Influence of possible confounders on Stroop performance
The present study revealed an association between 
Stroop performance and total number of episodes; 
strengthening previous findings indicating that number 
of affective episodes is negatively associated with execu-
tive functions (El-Badri et al. 2001). Equally, we observed 
a trend in a positive correlation between Stroop perfor-
mance and number of psychotropic medication groups. 
The influence of medication on cognitive performance 
has been reported controversially to date. Goswami et al. 
(2009), for example, did not find any influence of medical 
treatment on any type of cognitive performance, whereas 
Bora et al. (2009) reported an association between medi-
cation and the magnitude of impairment on psychomotor 
speed. Considering the Stroop test as a speed-dependent 
test could explain poorer performance among patients 
treated with a range of substances. In terms of depres-
sive symptoms, subthreshold symptoms did not influence 
Stroop performance in our findings, which confirms pre-
vious results (Bora et al. 2009).
General neuropsychological test performance
Compared to healthy controls, in our study euthymic 
bipolar patients showed a similar test performance across 
all cognitive domains with the exception of executive 
function. This is in contrast with previous meta-analyses 
stating that even in euthymia, bipolar patients show cog-
nitive impairment in nearly all domains (Robinson et al. 
2006; Torres et al. 2007; Arts et al. 2008; Kurtz and Ger-
raty 2009; Mann-Wrobel et  al. 2011; Porter et  al. 2015). 
In one study investigating cognitive subgroups, 41.4  % 
of the bipolar patients did not show any cognitive defi-
cits (Volkert et  al. 2015). Again here our study seems 
to contribute to somewhat of a controversial empirical 
database. In terms of executive functions, we reported 
significant differences in word fluency. This is in accord-
ance with several meta-analyses to date, which have all 
estimated executive functions to be particularly limited 
in this population (Robinson et  al. 2006; Torres et  al. 
2007; Arts et al. 2008; Kurtz and Gerraty 2009; Bora et al. 
2009).
Limitations
The results of this study are limited by its rather small 
sample size, though this can be partly counterbalanced by 
the huge range in our sample composition. Another nota-
ble point to consider is that participants were recruited 
through a university hospital, indicating a possible selec-
tion bias. It is possible that patients attending a specialist 
bipolar clinic received a more frequent, expert careplan 
than other typical bipolar patients attending community-
based services. Beyond that, nearly all of the patients are 
treated by multiple different medications, which could 
influence their Stroop performance. Therefore, the statis-
tically significant difference between patients and healthy 
controls on the Stroop might partly be due to patients’ 
treatment with polypharmacy. Finally, it should be noted 
that the broad age range in our sample may have affected 
a potential correlation between Stroop and BIS (Comalli 
et al. 1962).
Conclusions
In our study, both behavioral and self-reported impul-
sivities were increased within our patient group as com-
pared to controls; however, we did not find a correlation 
between these two constructs. Thus, our study highlights 
the importance of considering these aspects of impulsiv-
ity as two independent dimensional factors in bipolar dis-
order, which probably both influence the course of illness 
and functional outcome in respective ways. Our find-
ings suggest the possible usefulness of specific cognitive 
trainings for bipolar patients, with a focus on executive 
functions. Additionally, our findings indicate that it is 
particularly important to identify and prescribe a phar-
macotherapy that does not aggravate cognitive function-
ing in cases where performance is already compromised, 
or in cases of an advanced course of illness, to ensure lack 
of disruption in patients’ quality of life.
In future research, we recommend that studies with a 
longitudinal design investigate Stroop and BIS on a large 
sample of bipolar patients. Thus, one could investigate 
which of the two markers constitutes a better marker 
for the illness and may, therefore, be more suitable for 
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differentiating the most severe patients (e.g., those with 
substance misuse, more suicide attempts and a more 
severe course of illness). Beyond that, a study examining 
subjects at risk for bipolar disorder who are not medi-
cated yet could further investigate the relevance of inter-
ference control as a marker for bipolar disorder.
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